Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4951
iPath Select MLP ETN
ATMP
$640M
| $862K | ﹤0.01% |
28,118
-20,953
| -43% | -$634K |
|
|
CRON
4952
Cronos Group
CRON
$1.16B
| $862K | ﹤0.01% |
476,119
+129,423
| +37% | +$250K |
|
|
IOBT
4953
DELISTED
IO Biotech
IOBT
| $861K | ﹤0.01% |
789,461
-69,714
| -8% | -$65.8K |
|
4954
Nkarta
NKTX
$165M
| $860K | ﹤0.01% |
467,481
-1,286,863
| -73% | -$2.64M |
|
|
VENU
4955
Venu Holding Corp
VENU
$121M
| $859K | ﹤0.01% |
+92,823
| New | +$892K |
|
4956
Health Catalyst
HCAT
$132M
| $856K | ﹤0.01% |
189,026
-66,266
| -26% | -$351K |
|
|
CEV
4957
Eaton Vance California Municipal Income Trust
CEV
$73.6M
| $856K | ﹤0.01% |
85,419
+4,125
| +5% | +$41.9K |
|
4958
Neumora Therapeutics
NMRA
$321M
| $852K | ﹤0.01% |
852,372
+120,960
| +17% | +$207K |
|
4959
Dimensional International High Profitability ETF
DIHP
$6.59B
| $850K | ﹤0.01% |
31,568
+3,482
| +12% | +$93.1K |
|
|
DOYU
4960
DouYu International Holdings
DOYU
$136M
| $850K | ﹤0.01% |
113,759
+85,933
| +309% | +$984K |
|
4961
Angel Oak Income ETF
CARY
$1.39B
| $847K | ﹤0.01% |
40,799
+40,759
| +101,898% | +$844K |
|
|
MBX
4962
MBX Biosciences
MBX
$3.23B
| $846K | ﹤0.01% |
114,610
+90,775
| +381% | +$960K |
|
|
KEEL
4963
Keel Infrastructure Corp
KEEL
$2.04B
| $846K | ﹤0.01% |
1,073,091
-1,769,444
| -62% | -$2.34M |
|
4964
First Trust Dividend Strength ETF
FTDS
$39.8M
| $841K | ﹤0.01% |
16,521
+122
| +0.7% | +$6.29K |
|
4965
Xilio Therapeutics
XLO
$59.3M
| $837K | ﹤0.01% |
82,560
+11,034
| +15% | +$139K |
|
|
GREK
4966
Global X MSCI Greece ETF
GREK
$331M
| $833K | ﹤0.01% |
17,739
-7,174
| -29% | -$310K |
|
4967
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$352M
| $833K | ﹤0.01% |
15,873
-495
| -3% | -$25.9K |
|
4968
Flexsteel Industries
FLXS
$303M
| $832K | ﹤0.01% |
22,801
+3,754
| +20% | +$176K |
|
4969
Superior Group of Companies
SGC
$210M
| $830K | ﹤0.01% |
75,910
-28,077
| -27% | -$395K |
|
4970
iShares MSCI China A ETF
CNYA
$207M
| $829K | ﹤0.01% |
29,578
+678
| +2% | +$18.9K |
|
4971
FT Vest Fund of Buffer ETFs
BUFR
$10.4B
| $827K | ﹤0.01% |
27,871
+2,034
| +8% | +$62.2K |
|
4972
Fulcrum Therapeutics
FULC
$283M
| $823K | ﹤0.01% |
285,599
-1,246,133
| -81% | -$4.58M |
|
|
LPRO
4973
DELISTED
Open Lending Corp
LPRO
| $819K | ﹤0.01% |
296,772
-141,476
| -32% | -$703K |
|
4974
TScan Therapeutics
TCRX
$52.3M
| $818K | ﹤0.01% |
592,970
+180,112
| +44% | +$390K |
|
4975
VTEX
VTEX
$630M
| $816K | ﹤0.01% |
160,986
-54,339
| -25% | -$309K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.